BSE Live
Jan 27, 14:16Prev. Close
442.50
Open Price
442.60
Bid Price (Qty.)
446.05 (73)
Offer Price (Qty.)
447.45 (5)
NSE Live
Jan 27, 14:16Prev. Close
440.25
Open Price
445.75
Bid Price (Qty.)
446.85 (26)
Offer Price (Qty.)
447.40 (114)
| Key Financial Ratios of Thyrocare Technologies (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 9.79 | 10.57 | 13.04 | 8.08 | 5.74 | |
| Diluted EPS (Rs.) | 9.79 | 9.29 | 11.45 | 7.09 | 5.04 | |
| Cash EPS (Rs.) | 11.71 | 48.10 | 55.08 | 34.26 | 24.18 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 55.19 | 188.92 | 146.64 | 94.81 | 62.48 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 55.19 | 188.92 | 146.64 | 94.81 | 62.48 | |
| Dividend / Share(Rs.) | 3.76 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 35.63 | 137.37 | 122.97 | 100.91 | 72.04 | |
| PBDIT/Share (Rs.) | 15.88 | 68.93 | 63.37 | 50.05 | 36.02 | |
| PBIT/Share (Rs.) | 13.76 | 63.10 | 60.34 | 48.12 | 34.81 | |
| PBT/Share (Rs.) | 14.17 | 63.10 | 71.33 | 48.12 | 34.81 | |
| Net Profit/Share (Rs.) | 9.59 | 42.28 | 52.04 | 32.33 | 22.97 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 44.56 | 50.17 | 51.53 | 49.60 | 50.00 | |
| PBIT Margin (%) | 38.61 | 45.93 | 49.06 | 47.68 | 48.32 | |
| PBT Margin (%) | 39.77 | 45.93 | 58.00 | 47.68 | 48.32 | |
| Net Profit Margin (%) | 26.90 | 30.77 | 42.31 | 32.03 | 31.88 | |
| Return on Networth / Equity (%) | 17.37 | 22.37 | 35.48 | 34.09 | 36.75 | |
| Return on Capital Employed (%) | 24.16 | 19.28 | 29.50 | 26.14 | 25.74 | |
| Return on Assets (%) | 16.45 | 18.78 | 28.91 | 25.49 | 24.59 | |
| Total Debt/Equity (X) | 0.00 | 0.12 | 0.16 | 0.24 | 0.37 | |
| Asset Turnover Ratio (%) | 61.17 | 61.03 | 68.31 | 79.57 | 77.13 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 15.08 | 20.09 | 22.18 | 26.14 | 12.37 | |
| Quick Ratio (X) | 14.01 | 19.11 | 20.86 | 24.65 | 11.49 | |
| Inventory Turnover Ratio (X) | 25.53 | 23.82 | 25.60 | 21.40 | 19.46 | |
| Dividend Payout Ratio (NP) (%) | 39.19 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 32.09 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 60.81 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 67.91 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 60.80 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
24.10.2025
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
24.07.2025
Thyrocare Techn Standalone June 2025 Net Sales at Rs 178.89 crore, up 24.55% Y-o-Y
06.10.2021
Thyrocare Technologies Q2 PAT may dip 2.9% YoY to Rs 41.8 cr: Prabhudas Lilladher
12.07.2019
Thyrocare Technologies Q1 PAT may dip 6.5% YoY to Rs. 22.1 cr: Prabhudas Lilladher
12.04.2019
Thyrocare Technologies Q4 PAT seen up 18.1% YoY to Rs. 29.7 cr: Prabhudas Lilladher
17.04.2018
Thyrocare Technologies Q4 PAT seen up 68.7% YoY to Rs 32 cr: Edelweiss